Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...

In a unique finding, researchers at Georgetown's Lombardi Comprehensive Cancer Center discovered that when pancreatic cancer ...

In a unique finding, researchers at Georgetown's Lombardi Comprehensive Cancer Center discovered that when pancreatic cancer ...

The 2026 cancer statistics reveal improved survival rates but highlight persistent inequities in cancer incidence and ...

Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and begins in the cells lining the ...

Researchers found better detection, treatment and decreased smoking have been immensely helpful in reducing deaths due to ...

A new report from the American Cancer Society shows 7 in 10 cancer patients are living at least 5 years post-diagnosis.

A new Brazilian study has revealed the key role of the protein periostin and stellate pancreatic cells in allowing pancreatic ...

The five-year survival rate for all cancers combined in the US reached a landmark 70% for Americans diagnosed between 2015 ...

Furthermore, a near-doubling of 12-month survival was also achieved with the elraglusib regimen vs GnP alone (44.4% vs 22.3%), and at 24 months, the survival rate was nearly 5 times higher in the ...

Though the findings are positive overall, survival increases since the mid-1990s are especially notable for more fatal ...

But even these patients benefit from advances against cancer, the report said. Five-year survival rates have increased since ...